Takahashi, S.


Publications
2

Evaluation of Antibiotic Therapy for Eradication of “ Candidatus Helicobacter heilmannii”

Citation
Matsui et al. (2008). Antimicrobial Agents and Chemotherapy 52 (8)
Names
Ca. Helicobacter heilmannii
Abstract
ABSTRACT Triple-agent therapy with lansoprazole (15 mg/kg)-clarithromycin (50 mg/kg)-amoxicillin (50 mg/kg) twice daily for 7 days fully cleared “ Candidatus Helicobacter heilmannii” from infected mouse stomachs. Moreover, gastric mucosa-associated lymphoid tissue lymphoma-like lesions in the stomach nearly disappeared in the treated mice 4 months after the therapy.

“ Candidatus Helicobacter heilmannii” from a Cynomolgus Monkey Induces Gastric Mucosa-Associated Lymphoid Tissue Lymphomas in C57BL/6 Mice

Citation
Nakamura et al. (2007). Infection and Immunity 75 (3)
Names
Ca. Helicobacter heilmannii
Abstract
ABSTRACT Both Helicobacter pylori and “ Candidatus Helicobacter heilmannii” infections are associated with peptic ulcers, gastric adenocarcinoma, and gastric mucosa-associated lymphoid tissue (MALT) lymphomas. However, good animal models of H. pylori clinical diseases are rare. In this study, we aimed to establish an animal model of “ Candidatus Helicobacter heilmannii” gastric